Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of MX9405283ApublicationCriticalpatent/MX9405283A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Empleo de los compuestos de la fórmula (I), en donde uno de R1 y R2 esC1-7-alquilo y el otro es C1-7-alquilo o C2-6-alquenil-metilo, L esC1-11-alquileno o C2-11-alquenileno opcionalmente enlazado al grupo fenilovía un átomo de O o L es 1,4-fenilo, n=O o, donde L contiene un átomo deO, n=O o 1; Q es C1-7-alquilo, C2-10-alquenilo o un grupo de fórmula Q': Res H, halógeno, CF3, CN o NO2, R3 y R4 son, C1-4-alquilo o halógeno y R5es H o, donde R es H, H o halógeno, y sus sales de adición de ácidofarmacéuticamente aceptables para la preparación de medicamentosrebajadores de colesterol, así como nuevos compuestos que caen bajo lafórmula I.Use of the compounds of formula (I), in which one of R1 and R2 is C1-7-alkyl and the other is C1-7-alkyl or C2-6-alkenyl-methyl, L isC1-11-alkylene or C2- 11-alkenylene optionally linked to the phenyl group via an atom of O or L is 1,4-phenyl, n = O or, where L contains an atom of O, n = O or 1; Q is C1-7-alkyl, C2-10-alkenyl or a group of formula Q ': Res H, halogen, CF3, CN or NO2, R3 and R4 are, C1-4-alkyl or halogen and R5 is H or, where R is H, H, or halogen, and its pharmaceutically acceptable acid addition salts for the preparation of cholesterol-lowering drugs, as well as novel compounds falling under formula I.
MX9405283A1993-07-141994-07-12
USE OF PHENALKYLAMINS FOR THE MANUFACTURE OF MEDICINES TO REDUCE CHOLESTEROL AND THE MEDICINES THAT INCLUDE THEM.
MX9405283A
(en)
AMINOTIOFENCARBOXAMIDAS, A PROCEDURE FOR ITS PREPARATION, USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AND A PROCEDURE TO OBTAIN THESE PHARMACEUTICAL PREPARATIONS
THENOPYRIMIDINES, A PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL PREPARATIONS THAT CONSTITUTE THEM AND A PROCEDURE TO OBTAIN THESE PHARMACEUTICAL PREPARATIONS
COMPOUNDS DERIVED FROM ACID [4- (INDAZOL-3-IL) -PIPERIDIN-1-IL] -ACETIC, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, THE USE OF THEMSELVES IN THE PREPARATION OF A THERAPEUTIC AGENT, METHOD OF TREATMENT AND INTERMEDIATE COMPOUNDS.
TETRAHYDROCARBAZOL DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A DISEASE IN WHICH AN AGONIST SIMILAR TO 5-HT1 IS INDICATED.